Thus, it has been suggested that MMP9 is a marker of carotid plaque instability (64) or plaque rupture (65, 66) and a predictor of adverse clinical outcome in patients with acute coronary syndrome (66). This evidence concerns the gene MMP9 and acute coronary syndrome.